You are here
Clinical Trials: Spinal Cord Injuries
Each Clinical Trial will open in a new browser window or tab.
Conditions: Spinal Cord Injuries; Tetraplegia
Intervention: Device: Testing of MyHand-SCI Device
Sponsors: Columbia University; National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting
Intervention: Device: Testing of MyHand-SCI Device
Sponsors: Columbia University; National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting
Condition: Spinal Cord Injuries
Intervention: Biological: AlloRx
Sponsor: The Foundation for Orthopaedics and Regenerative Medicine
Recruiting
Intervention: Biological: AlloRx
Sponsor: The Foundation for Orthopaedics and Regenerative Medicine
Recruiting
Condition: Spinal Cord Injury Cervical
Interventions: Drug: WJ-MSC (XCEL-UMC-BETA); Drug: Placebo
Sponsors: Banc de Sang i Teixits; Institut Guttmann; Academic Research Organization (ARO) - VHIR
Not yet recruiting
Interventions: Drug: WJ-MSC (XCEL-UMC-BETA); Drug: Placebo
Sponsors: Banc de Sang i Teixits; Institut Guttmann; Academic Research Organization (ARO) - VHIR
Not yet recruiting
Condition: Spinal Cord Injuries
Intervention: Biological: autologous adipose derived mesenchymal stem cells
Sponsor: The Foundation for Orthopaedics and Regenerative Medicine
Recruiting
Intervention: Biological: autologous adipose derived mesenchymal stem cells
Sponsor: The Foundation for Orthopaedics and Regenerative Medicine
Recruiting
Conditions: Spinal Cord Injury, Acute; Spinal Cord Injury at C4 Level With Complete Lesion; Spinal Cord Injury at C5-C7 Level With Complete Lesion
Intervention: Biological: Neural precursor cells derived from human embryonic stem cell line
Sponsors: S.Biomedics Co., Ltd.; Linical Co., Ltd.; Yonsei University
Not yet recruiting
Intervention: Biological: Neural precursor cells derived from human embryonic stem cell line
Sponsors: S.Biomedics Co., Ltd.; Linical Co., Ltd.; Yonsei University
Not yet recruiting
Condition: Spinal Cord Injury
Interventions: Biological: Autologous bone marrow-derived mononuclear cells; Drug: Placebo
Sponsor: Shanghai Changzheng Hospital
Not yet recruiting
Interventions: Biological: Autologous bone marrow-derived mononuclear cells; Drug: Placebo
Sponsor: Shanghai Changzheng Hospital
Not yet recruiting
Conditions: Spinal Cord Injuries; Paralysis
Interventions: Other: Best Medical Management: Occupational and Physical Therapy; Biological: Autologous, Adipose Derived Mesenchymal Stem Cells
Sponsor: Allan Dietz
Recruiting
Interventions: Other: Best Medical Management: Occupational and Physical Therapy; Biological: Autologous, Adipose Derived Mesenchymal Stem Cells
Sponsor: Allan Dietz
Recruiting
Condition: Spinal Cord Injuries
Interventions: Biological: Collection and expansion of BM-MSC; Diagnostic Test: VI-SCI evaluation and patients' follow up
Sponsor: University of Jordan
Recruiting
Interventions: Biological: Collection and expansion of BM-MSC; Diagnostic Test: VI-SCI evaluation and patients' follow up
Sponsor: University of Jordan
Recruiting
Condition: Spinal Cord Injuries
Intervention: Biological: Neuro-Cells
Sponsor: Neuroplast
Not yet recruiting
Intervention: Biological: Neuro-Cells
Sponsor: Neuroplast
Not yet recruiting
Conditions: Spinal Cord Injuries; Tendinopathy; Rotator Cuff Tears; Shoulder Pain
Interventions: Device: Lipogems; Drug: Dexamethasone
Sponsor: Kessler Foundation
Recruiting
Interventions: Device: Lipogems; Drug: Dexamethasone
Sponsor: Kessler Foundation
Recruiting
2022 AlphaMed Press ©